INGENUITY CREATES MILESTONES

OF INTELLIGENT MANUFACTURING

Toumai® Robot Enables Three Telesurgeries Across 5,000 km in a Single Day
2025-08-11 GMT+8 PM 07:00

Shanghai & Kashgar, China, 25 August, 2025 — Three leading surgeons in Shanghai used the same Toumai® Endoscopic Surgical Robot (Toumai®) to consecutively perform telesurgeries for three patients in Kashgar, over 5,000 kilometers away. This marks a world first: multiple experts successfully performed high-complexity, cross-specialty telesurgeries using a single surgical robot. It highlights Toumai®’s stability and adaptability under continuous telesurgery operation. 

 

The telesurgeries were conducted and live streamed at the Toumai® DeepNet™ Telesurgery Smart Connection Center of MicroPort® MedBot™.

 

Highlights of the Day

 

  • Radical Prostatectomy: Prof. Jiahua Pan, Director of Urology at Shanghai Renji Hospital, Shanghai Jiao Tong University School of Medicine, demonstrated Toumai®’s articulating precision and 3D vision to complete nerve-sparing dissection in a complex prostate cancer case.

 

  • Left Hemicolectomy for Colon Cancer: Prof. Ren Zhao, Vice President and Chief of General Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, successfully managed dense intra-abdominal adhesions and a large tumor mass, leveraging Toumai®’s stable instrument reach to achieve full oncologic resection.

 

 

  • Single-Port Total Hysterectomy with Bilateral Salpingo-Oophorectomy: Prof. Guizhu Wu, Director of Gynecology at Shanghai First Maternity and Infant Hospital, utilized Toumai®’s multi-arm single-port system to perform delicate dissection and suturing in the narrow pelvic cavity.

Experts speaking during the live broadcast emphasized that these cases were not only a technological milestone but also a practical model for bringing advanced medical surgical expertise closer to patients in remote areas.

 

Toumai® has gained broad clinical adoption across urology, general surgery, thoracic surgery, gynecology, pediatric surgery, and thyroid and breast surgery. Looking ahead, the ongoing use of Toumai® is expected to further support clinical practice in underserved regions, while demonstrating the potential of telesurgery to improve patient access and outcomes worldwide.  

 

More information is available at: www.medbotsurgical.com/en

For more information,
please click here.